DEMONSTRATION OF BLOCKING IMMUNOGLOBULINS G, HAVING A HETEROGENEOUS BEHAVIOUR, IN SERA OF PATIENTS WITH GRAVES' DISEASE: POSSIBLE COEXISTENCE OF DIFFERENT AUTOANTIBODIES DIRECTED TO THE TSH RECEPTOR
- 1 February 1988
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 28 (2) , 147-156
- https://doi.org/10.1111/j.1365-2265.1988.tb03650.x
Abstract
SUMMARY: Previous studies by us and others have shown that Graves' immunoglobulins G (IgGs) behaved as agonists or even antagonists of TSH. In this paper we have looked for the existence of IgG preparations without any thyroid stimulatory activity but able to significantly block the action of TSH in 128 hyperthyroid Graves' patients. The presence of TSH‐binding inhibiting antibodies (TBIAb) and that of thyroid stimulating antibodies (TSAb) was evaluated by a radioreceptor assay using solubilized thyroid plasma membranes and by assaying the adenylate cyclase (AC) function of thyroid plasma membranes, respectively. Seventeen IgGs were negative for TSAb but positive for TBIAb in the screening, using only one concentration of IgG. Three kinds of activity were investigated in these IgGs at different doses: (1) TSH‐binding inhibiting activity; (2) thyroid AC stimulating activity; and (3) the inhibition of TSH‐induced AC stimulation. The results showed that the level of activity was not always dose‐dependent. A significant (>20%) inhibition of the TSH‐dependent AC stimulation was present in 15 of the 17 IgGs examined: this inhibition was more elevated at lower than at higher doses in two preparations. No significant correlation was found between the three activities. In short, we have been able to demonstrate the existence of ‘blocking’ antibodies, apparently without any stimulatory activity, in some patients with Graves' disease. The diphasic pattern of the dose‐response curves of some IgGs and the lack of correlation between the different activities can be explained by the co‐existence in the sera of Graves' patients of different autoantibodies varying in concentration, binding affinity constant and intrinsic biological activity.This publication has 17 references indexed in Scilit:
- Studies on multiple thyroid cell membrane-directed antibodies in Graves' disease.Journal of Clinical Investigation, 1985
- Primary Myxedema with Thyrotrophin-Binding Inhibitor ImmunoglobulinsAnnals of Internal Medicine, 1985
- Blocking activity to action of thyroid stimulating hormone in serum from patients with primary hypothyroidism.BMJ, 1984
- Autoimmune Thyroid Disease: Developments in Our UnderstandingEndocrine Reviews, 1984
- A sensitive method for assaying thyroid stimulating immunoglobulins of Graves' disease: use of the guanyl nucleotide-amplified thyroid adenylate cyclase assayActa Endocrinologica, 1983
- COMPARISON BETWEEN THYROID STIMULATING AND TSH-BINDING INHIBITING IMMUNOGLOBULINS OF GRAVES' DISEASEClinical Endocrinology, 1981
- [27] Measurement of thyrotropin receptor antibodiesPublished by Elsevier ,1981
- Clinical Significance of Assay of Thyroid-Stimulating Antibody in Graves' DiseaseAnnals of Internal Medicine, 1980
- THYROID-STIMULATING IMMUNOGLOBULINS IN GRAVES' DISEASEThe Lancet, 1974